Printer Friendly

More on PSA testing to detect early prostatic cancer.

We recently reported on the use of the test for prostate-specific antigen (PSA) as an important adjunct to the rectal examination in screening for cancer of the prostate. Although some authorities have believed that it should be routinely used, others have been concerned that the PSA test can be elevated in the absence of cancer--giving a false positive.

Now a study reported in the April 22 Journal of the American Medical Association shows that the level of PSA may begin rising from seven to 25 years before cancer of the prostate becomes evident by other means. This rise is more rapid than that among men with only benign prostatic enlargement.

"Our study shows that if you look at how quickly the PSA level is going up, you can reduce the error rate for detecting cancer from 40 percent down to 10 percent," said Dr. Jay Pearson of the National Institute on Aging. Dr. Pearson is co-author of the study with a research team led by Dr. H. Ballentine Carter of the Johns Hopkins University School of Medicine.

The researchers hope their findings will greatly reduce the number of unnecessary biopsies done among men who might have cancer, based on rectal examination, but who are found to have only benign prostatic enlargement. (Almost all males endure benignly enlarged prostates as they grow older.)

Compared to the cost ($350-$500) and the inconvenience of biopsy, the PSA blood test (which costs about $35) is a reasonable addition to the annual rectal examination that all men over 50 should have.

American doctors can expect to diagnose 132,000 cases of prostate cancer this year. Although a single PSA test result may have little significance, having one done each year will show a trend that quickly appears if prostate cancer is beginning to develop--and often long before it is detected by rectal examination.
COPYRIGHT 1992 Benjamin Franklin Literary & Medical Society, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:prostate-specific-antigen
Publication:Medical Update
Date:Jun 1, 1992
Previous Article:"Go jump in the lake!" (health benefits of swimming)
Next Article:A rough shaking.

Related Articles
Prostate cancer - the American male's silent killer.
The neglected sex gland: a protein in the blood forecasts cancer of the prostate.
Interpreting the PSA - the key to adequate prostate cancer screening.
Prostate specific antigen and prostate cancer.
Prostate Cancer--The Most Common Cancer in Men.
What Every Man Should Know About the Prostate.
The clinical and economic benefits of PSA and fPSA testing.
Prostate-cancer testing changes.
Serial serum prostate specific antigen measurements over time in a patient presenting with a metastatic adenocarcinoma of unknown origin.
Life-saving advances in prostate cancer testing.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters